Details for Patent: 11,723,869
Which drugs does patent 11,723,869 protect, and when does it expire?
Patent 11,723,869 protects LUMASON and is included in one NDA.
This patent has twenty-nine patent family members in twelve countries.
Summary for Patent: 11,723,869
| Title: | Freeze-dried product and gas-filled microvesicles suspension |
| Abstract: | A method of manufacturing a suspension of gas-filled microvesicles by reconstituting a freeze-dried product and a suspension obtained according to said method, where the freeze-dried product has been subjected to a thermal treatment. |
| Inventor(s): | Philippe Bussat, Anne Lassus, Jean Brochot, Michel Schneider, Feng Yan |
| Assignee: | Bracco Suisse SA |
| Application Number: | US17/872,974 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,723,869
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | USE IN ADULT AND PEDIATRIC PATIENTS WITH SUBOPTIMAL ECHOCARDIOGRAMS TO OPACIFY THE LEFT VENTRICULAR CHAMBER AND TO IMPROVE THE DELINEATION OF THE LEFT VENTRICULAR ENDOCARDIAL BORDER | ⤷ Start Trial | |||
| Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | USE IN ULTRASONOGRAPHY OF THE URINARY TRACT IN PEDIATRIC PATIENTS FOR THE EVALUATION OF SUSPECTED OR KNOWN VESICOURETERAL REFLUX | ⤷ Start Trial | |||
| Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | USE WITH ULTRASOUND OF THE LIVER IN ADULT AND PEDIATRIC PATIENTS TO CHARACTERIZE FOCAL LIVER LESIONS | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,723,869
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020274620 | ⤷ Start Trial | |||
| Australia | 2020276679 | ⤷ Start Trial | |||
| Brazil | 112021021791 | ⤷ Start Trial | |||
| Brazil | 112021022185 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
